Skip to main content
. 2017 Sep 28;8(56):95791–95798. doi: 10.18632/oncotarget.21327

Figure 1.

Figure 1

Survival rate analysis in basaloid subgroup A (A); in non-basaloid subgroup B (B); disease specific survival comparison between two subgroups (C).